|
|
Title | Creator | Description | Identifier |
1 |
|
Safety and Tolerability of Acetazolamide | Martin ten Hove, MD, M.Eng, FRCS(C), Queen's University, Kingston, ON | Idiopathic intracranial hypertension (IIH) is a disease of unknown etiology that occurs primarily in young obese women with an estimated incidence of 0.9/100,00 in the general population1. The current medical treatment paradigm for IIH aims to decrease intracranial pressure (ICP) by decreasing the p... | 20150225_nanos_hottopic2_04-1 |
2 |
|
Safety and Tolerability of Acetazolamide | Martin ten Hove, MD, M.Eng, FRCS(C), Queen's University, Kingston, ON | Idiopathic intracranial hypertension (IIH) is a disease of unknown etiology that occurs primarily in young obese women with an estimated incidence of 0.9/100,00 in the general population1. The current medical treatment paradigm for IIH aims to decrease intracranial pressure (ICP) by decreasing the ... | 20150225_nanos_hottopic2_04 |
3 |
|
Safety and Tolerability of Acetazolamide (Video) | Martin ten Hove, MD, M.Eng, FRCS(C), Queen's University, Kingston, ON | Idiopathic intracranial hypertension (IIH) is a disease of unknown etiology that occurs primarily in young obese women with an estimated incidence of 0.9/100,00 in the general population1. The current medical treatment paradigm for IIH aims to decrease intracranial pressure (ICP) by decreasing the ... | 20150225_nanos_hottopic2_04 |